指南与共识心脑血管急症重症综合管理与镇静镇痛

丙戊酸与碳青霉烯类药物的相互作用:综述与建议

Valproate Interaction With Carbapenems: Review and Recommendations.
指南 / 共识 · Hosp Pharm · 2019-02-22
一句话结论作者认为应避免碳青霉烯类与丙戊酸衍生物联用,因可致丙戊酸血药浓度低于治疗水平;若必须联用,推荐加用另一种抗癫痫药并监测丙戊酸血药浓度。

本文综述了1998年1月至2018年11月间Medline(通过PubMed)、Ovid、Embase、Cochrane图书馆及主要期刊手工检索的文献,纳入关于丙戊酸衍生物与碳青霉烯类抗生素(美罗培南、厄他培南、亚胺培南、多利培南)联用的临床试验与病例报告。结果显示,碳青霉烯类可降低丙戊酸血药浓度至亚治疗水平,部分患者出现癫痫发作;停用碳青霉烯后丙戊酸浓度通常短期内恢复正常。作者结论认为一般应避免两者联用,可考虑其他抗菌药物替代;若必须联用碳青霉烯,推荐加用另一种抗癫痫药,并在不可避免的联用中监测丙戊酸血药浓度。

要点

  • 碳青霉烯类(美罗培南、厄他培南、亚胺培南、多利培南)可降低丙戊酸衍生物血药浓度至亚治疗水平,部分患者出现癫痫发作。
  • 停用碳青霉烯类后,丙戊酸血药浓度通常短期内恢复正常。
  • 作者认为一般应避免碳青霉烯类与丙戊酸衍生物联用,可考虑其他抗菌药物替代碳青霉烯类。
  • 若必须联用碳青霉烯类,作者推荐加用另一种抗癫痫药。
  • 碳青霉烯-丙戊酸联用不可避免时,需监测丙戊酸血药浓度。

适用人群与场景

  • 使用丙戊酸衍生物抗癫痫治疗、因感染需使用碳青霉烯类抗生素的患者(急诊科医师、神经科医师、药师需知晓该相互作用)。

处置流程与药物剂量

  • 作者认为一般应避免碳青霉烯类抗生素与丙戊酸衍生物联用。
  • 可考虑其他抗菌药物替代碳青霉烯类。
  • 若必须联用碳青霉烯类,作者推荐加用另一种抗癫痫药。
  • 碳青霉烯-丙戊酸联用不可避免时,需监测丙戊酸血药浓度。

红旗征与不能漏的情况

  • 碳青霉烯类降低丙戊酸血药浓度至亚治疗水平,可能使患者暴露于癫痫失控风险。

研究设计与关键结果

  • 综述纳入1998年1月至2018年11月的相关文献,汇总患者、碳青霉烯种类、丙戊酸剂量与浓度、相互作用严重程度及临床结局。
  • 少数临床试验和多个病例报告显示,美罗培南、厄他培南、亚胺培南、多利培南可降低丙戊酸衍生物血药浓度至亚治疗水平,部分患者出现癫痫发作。
  • 加用碳青霉烯后丙戊酸血药浓度可能显著降低,停用碳青霉烯后通常短期内恢复正常。

证据类型、等级与局限

  • 证据类型:文献综述,纳入少数临床试验和多个病例报告。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为应避免碳青霉烯类与丙戊酸衍生物联用,可考虑其他抗菌药物替代碳青霉烯类。
  • 若必须联用碳青霉烯类,作者推荐加用另一种抗癫痫药,并监测丙戊酸血药浓度。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Introduction: Valproic acid is a commonly used antiepileptic drug. Combining valproate derivatives with carbapenem antibiotics is associated with a potential drug interaction that decreases serum concentration of valproate and may expose the patient to uncontrolled seizure risk from valproate subtherapeutic concentration. Raising awareness of this drug interaction among health care providers including emergency department physicians, neurologists, and pharmacists is highly needed. The aim of this article was to review the current literature about the potential drug interaction resulting from combining valproate derivatives with carbapenem antibiotics and to establish therapeutic recommendations regarding their use together. Methods: A review of the literature was conducted using Medline (through PubMed), Ovid, Embase, Cochrane library using the following keywords: valproate, valproic acid, carbapenem, ertapenem, doripenem, meropenem, imipenem, and valproate drug interaction. In addition, a manual search through major journals for articles referenced in PubMed was performed. Related publications from January 1998 till November 2018 were included in the initial search. Relevant publications were reviewed, and data regarding patients, type of carbapenem used, valproic acid dosing and level, interaction severity, and clinical outcome were summarized. Results and Discussion: Few clinical trials and multiple case reports have shown that carbapenem antibiotics including meropenem, ertapenem, imipenem, and doripenem can decrease the serum concentration of valproate derivatives leading to a subtherapeutic serum concentration and seizures in some patients. Valproic acid serum concentration may be significantly decreased with addition of a carbapenem antibiotic but generally return toward normal shortly after discontinuation of the carbapenem antibiotic. Conclusions: Generally, the concurrent use of carbapenem antibiotics with valproate derivatives should be avoided due to the potential of drug-drug interaction that results in subtherapeutic valproate serum concentration. Other antimicrobial agents should be considered as alternatives to carbapenems but if a concurrent carbapenem is necessary, using an additional antiepileptic agent is recommended. Therapeutic drug monitoring of valproate serum concentrations is warranted when a carbapenem-valproic acid combination therapy is unavoidable.

来源:Hosp Pharm,查看原文。版权归原作者所有。

参考来源

  1. Al-Quteimat O, Laila A. Valproate Interaction With Carbapenems: Review and Recommendations. Hosp Pharm. 2019. PMID: 32508355. doi:10.1177/0018578719831974

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。